Skip to content
My WebMD Sign In, Sign Up

Depression Health Center

Font Size

Newer Antidepressants Work Equally Well, Study Finds

But Medicines Do Differ in Side Effects, How Quickly They Work
By
WebMD Health News
Reviewed by Laura J. Martin, MD

Dec. 5, 2011 -- Newer antidepressants are all about equally effective, according to a new analysis, but that doesn't mean they work the same way for everyone.

"Contrary to drug industry claims, scientific evidence does not support the choice of one drug over another based solely on better effectiveness," says researcher Gerald Gartlehner, MD, MPH, a clinical epidemiologist at Danube University in Austria.

Gartlehner and his team analyzed studies that compared popular newer antidepressants such as Celexa (citalopram), Cymbalta (duloxetine), Prozac (fluoxetine), Wellbutrin (bupropion), Zoloft (sertraline), and others. They did find differences among the medicines for side effects such as sexual dysfunction and weight gain, and in how quickly the medications took effect.

The study is published in the Annals of Internal Medicine. It was funded by the Agency for Healthcare Research and Quality.

Tracking the Newer Antidepressants

Most newer antidepressants prescribed to treat major depressive disorder are the so-called second-generation drugs. They work by affecting levels of brain chemicals such as serotonin or norepinephrine.

More than 16% of adults will be affected with major depressive disorder at some point, the researchers write.

Experts have debated which of the newer antidepressants are most effective. "Many individual studies have compared antidepressants for the treatment of depression," Gartlehner tells WebMD. "The results of the individual studies are mixed and sometimes contradictory, which can make it difficult for consumers to understand and interpret the results."

The researchers found 234 previously published, scientifically sound studies on antidepressants. They re-evaluated the results.

They looked at studies that compared two drugs to each other or a drug to a placebo. The majority of the studies, 77%, were funded by pharmaceutical companies. Some of the researchers also report consultant work for Novartis and for Takeda Pharmaceutical Company. Among the findings:

  • Overall effectiveness did not differ much among the drugs.
  • 37% of people with acute depression who took the drugs did not improve by six or 12 weeks.
  • 53% did not recover fully from depression.

Today on WebMD

contemplation
Differences between feeling depressed or blue.
light therapy
What are the symptoms?
 
depressed man sitting on hallway floor
Learn the truth about this serious illness.
Sad woman looking out of the window
Tips to stay the treatment course.
 
Woman taking pill
Article
Woman jogging outside
Feature
 
man screaming
Article
woman standing behind curtains
Article
 
Pet scan depression
Slideshow
antidepressants slideshow
Article
 
pill bottle
Article
Winding path
Article